Correlation Between Bayer AG and Novartis

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Bayer AG and Novartis at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bayer AG and Novartis into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bayer AG and Novartis AG ADR, you can compare the effects of market volatilities on Bayer AG and Novartis and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bayer AG with a short position of Novartis. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bayer AG and Novartis.

Diversification Opportunities for Bayer AG and Novartis

0.9
  Correlation Coefficient

Almost no diversification

The 3 months correlation between Bayer and Novartis is 0.9. Overlapping area represents the amount of risk that can be diversified away by holding Bayer AG and Novartis AG ADR in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Novartis AG ADR and Bayer AG is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bayer AG are associated (or correlated) with Novartis. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Novartis AG ADR has no effect on the direction of Bayer AG i.e., Bayer AG and Novartis go up and down completely randomly.

Pair Corralation between Bayer AG and Novartis

Assuming the 90 days horizon Bayer AG is expected to under-perform the Novartis. In addition to that, Bayer AG is 2.88 times more volatile than Novartis AG ADR. It trades about -0.19 of its total potential returns per unit of risk. Novartis AG ADR is currently generating about -0.27 per unit of volatility. If you would invest  11,695  in Novartis AG ADR on September 16, 2024 and sell it today you would lose (1,859) from holding Novartis AG ADR or give up 15.9% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Strong
Accuracy100.0%
ValuesDaily Returns

Bayer AG  vs.  Novartis AG ADR

 Performance 
       Timeline  
Bayer AG 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Bayer AG has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.
Novartis AG ADR 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Novartis AG ADR has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in January 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Bayer AG and Novartis Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Bayer AG and Novartis

The main advantage of trading using opposite Bayer AG and Novartis positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bayer AG position performs unexpectedly, Novartis can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Novartis will offset losses from the drop in Novartis' long position.
The idea behind Bayer AG and Novartis AG ADR pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.

Other Complementary Tools

Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Commodity Directory
Find actively traded commodities issued by global exchanges
Global Correlations
Find global opportunities by holding instruments from different markets